CausalSentinel

Protein Dossier — METAP2 (Methionine aminopeptidase 2)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Mean platelet volume -0.0813 0.0047 4.12e-67 Wald ratio 1 trans NA
Platelet count 26 1.73 5.20e-51 Wald ratio 1 trans NA
Systemic lupus erythematosus 0.502 0.171 0.00333 Wald ratio 1 trans NA
Juvenile idiopathic arthritis 0.511 0.201 0.0108 Wald ratio 1 trans NA
Non-cancer illness code self-reported: hypertension 0.037 0.0146 0.0111 Wald ratio 1 trans NA
Years of schooling -0.0325 0.0145 0.0244 Wald ratio 1 trans NA
Knee and hip osteoarthritis 0.176 0.0795 0.0265 Wald ratio 1 trans NA
Schizophrenia -0.0875 0.0398 0.0278 Wald ratio 1 trans NA
Diagnoses - main ICD10: N92 Excessive frequent and irregular menstruation 0.12 0.0549 0.0295 Wald ratio 1 trans NA
Diagnoses - main ICD10: I48 Atrial fibrillation and flutter 0.157 0.0721 0.0298 Wald ratio 1 trans NA
2hr glucose 0.166 0.0795 0.0365 Wald ratio 1 trans NA
Squamous cell lung cancer 0.202 0.0978 0.0385 Wald ratio 1 trans NA
…and 96 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-3170_6_1 AMPM2 Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

18 association rows across 16 traits (16 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Height 7e-65 rs2596741 2 GCST90245848 no MR -> candidate analysis
High light scatter reticulocyte percentage of red cells 3e-53 rs784487 1 GCST90002386 no MR -> candidate analysis
High light scatter reticulocyte count 1e-51 rs784487 1 GCST90002385 no MR -> candidate analysis
Immature fraction of reticulocytes 1e-45 rs34994986 2 GCST90002387 no MR -> candidate analysis
Reticulocyte count 3e-32 rs784487 1 GCST90002405 no MR -> candidate analysis
height (mean, inv-normal transformed) 9e-17 rs301033 1 GCST90479635 no MR -> candidate analysis
Height (maximum, inv-normal transformed) 6e-16 rs301033 1 GCST90479634 no MR -> candidate analysis
Circulating METAP2 levels 8e-16 rs784487 1 GCST90860036 no MR -> candidate analysis
METAP2 protein levels 1e-14 rs784487 1 GCST90469894 no MR -> candidate analysis
Core binding factor acute myeloid leukemia 2e-10 rs301009; rs301011; rs11614671; rs4762519; rs11519597; rs2769469; rs2596741; rs3794261; rs1057739; rs301026; rs301024; rs7974458; rs301003; rs10777699; rs3812813; rs11108094; rs10498964; rs2769444 1 GCST008413 no MR -> candidate analysis
Sex hormone-binding globulin levels 8e-10 rs528806375 1 GCST90012107 no MR -> candidate analysis
Sex hormone-binding globulin levels adjusted for BMI 2e-9 rs528806375 1 GCST90012106 no MR -> candidate analysis
…and 4 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 166 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
preeclampsia 0.441 common-variant locus no MR -> candidate analysis
type 2 diabetes mellitus 0.266 common-variant locus no MR -> candidate analysis
sialolithiasis 0.142 common-variant locus no MR -> candidate analysis

Of the 3 rows above, 3 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 2 known modulators (Methionine aminopeptidase 2)
gnomAD constraint pLI=0.16, LOEUF=0.588 — LoF-tolerant
GWAS Catalog 70 unique SNPs / 140 rows
ClinVar 63 records; 0 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance